Sodium phosphate cotransporters are a type of membrane protein that primarily regulate the co-transport of sodium (Na
+) and phosphate (PO
43-). These transporters utilize the concentration gradient of sodium ions inside and outside the cell, employing an active transport mechanism to facilitate the movement of phosphate across the cell membrane, playing a central role in the distribution and utilization of phosphate within the body. In mammals, these transporters are primarily composed of members from the SLC34 and SLC20 families. The SLC34 family includes NaPi-IIa, NaPi-IIb, and NaPi-IIc, which are primarily expressed in the apical membrane of epithelial cells in the kidneys and intestines, responsible for the reabsorption and intake of phosphate, constituting the rate-limiting step in trans-epithelial phosphate transport. The SLC20 family includes Pit-1 and Pit-2, which were initially identified as receptors for retroviruses, but were later found to also function as sodium phosphate cotransporters, mainly involved in regulating intracellular phosphate levels and widely expressed in various tissues such as bones, kidneys, and intestines. In the cardiovascular system, Pit-1 may play a role in vascular calcification under conditions of hyperphosphatemia. Sodium phosphate cotransporters are associated with renal metabolic diseases such as phosphate wasting syndrome, making them potential therapeutic targets
[1][2].